Vivalto Santé plans to expand its healthcare network by acquiring 10 additional facilities across France and Europe, emphasizing its commitment to innovative medical partnerships and improved service delivery.
Target Information
Vivalto Santé is a leading player in the French healthcare system, operating over 50 hospitals and clinics across the country. As a pioneering enterprise with a mission in the health sector, Vivalto Santé seeks to reinforce its unique "Third Way" model, which emphasizes both medical and capital partnerships, as it pursues organic and external growth strategies both in France and internationally.
In September 2023, Vivalto Santé established a Medical Operations Committee (CMO) to enhance its operational medical performance while further involving physicians in strategic decision-making. This initiative complements the Strategic Medical Committee (CMS) created in 2022 to guide the group’s medical deliberations.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The healthcare industry in France is undergoing significant transformations, marked by a pressing demand for better healthcare services amid increasing operational pressures. The introduction of voluntary integrated healthcare network
Similar Deals
Kemin Industries → AFYREN
2025
GENEO Capital Entrepreneur → MLab
2025
Bpifrance → Groupe Softway Medical
2025
Turenne Santé, Sodero → Vedalab
2024
Nord Est Partenaires, Carvest → HTC Santé
2024
Vivalto Santé
invested in
3 establishments in France and 7 establishments in Europe
in 2024
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $65M